Recombinant monoclonal thyrotropin-stimulation blocking antibody (TSBAb) established from peripheral lymphocytes of a hypothyroid patient with primary myxedema
- 21 Downloads
Anti-TSH receptor antibodies (TRAbs) have been known to be involved in Graves’ disease and primary hypothyroidism. We previously isolated and reconstituted immunoglobulin (Ig) genes of Epstein-Barr virus-transformed B cell clones producing monoclonal TRAbs obtained from Graves’ patients. In the present study, we performed a similar experiment using a B cell clone, 32A-5, derived from a patient with primary hypothyroidism. The variable region genes of Ig heavy (H) and light (L) chains were isolated and sequenced from the 32A-5 clone. A significant number of somatic mutations were found in variable regions of H and L chain gene segments. Each pair of H and L chain cDNAs was ligated into an expression vector for IgG1 production and stably introduced into myeloma cells. The transfectants were injected ip into BALB/c mice to yield ample volume of the antibody for following applications. Interactions of recombinant 32A-5 with Graves’ sera with varying thyroid-stimulating antibody (TSAb) activities were studied. The recombinant antibody tended to suppress TSAb activities in 10 of 15 Graves’ sera, in which four were significantly inhibited. In summary, this is the first study to analyze human monoclonal TSH-stimulation blocking antibodies (TSBAb) at the molecular level. Use of human recombinant monoclonal TSBAb may be an analytical tool for molecular-basis etiology and an alternative therapeutic path for Graves’ disease.
KeywordsImmunoglobulin Heavy Chain Diversity TSAb Activity Primary Myxedema Germline Segment Suppress Thyroid Hormone
Unable to display preview. Download preview PDF.
- 5.Li H, Akamizu T, Okuda J, et al. Isolation of Epstein-Barr virus-transformed lymphocytes producing IgG class monoclonal antibodies using a magnetic cell separator (MACS): preparation of thyroid-stimulating IgG antibodies form patients with Graves’ disease. Biochem Biophys Res Commun. 1995, 207: 985–93.PubMedCrossRefGoogle Scholar
- 9.Akamizu T, Moriyama K, Miura M, Saijo M, Matusda F, Nakao K. Characterization of recombinant monoclonal anti- thyrotropin receptor antibodies (TSHRAbs) derived from lymphocytes of patients with Graves’ disease: Epitope and binding study of two stimulatory TSHRAbs. Endocrinology 1999, 140: 1594–1601.PubMedGoogle Scholar
- 14.Ichihara Y, Matsuoka H, Kurosawa. Y. Organization of human immunoglobulin heavy chain diversity gene loci. EMBO J 1988, 13: 4141–50.Google Scholar
- 15.Buluwela L, Alberson DG, Sherrington P, Rabbitts PH, Spurr N, Rabbitts TH. The use of chromosomal translocations to study human immunoglobulin gene organization: mapping DH segments within 35 kb of the Cm gene and identification of new DH locus. EMBO J 1988, 7: 2003–10.PubMedCentralPubMedGoogle Scholar
- 16.Honjo T, Alt FW. Immunoglobulin genes. 3rd ed. London: Academic Press 1995.Google Scholar
- 19.Ikematsu W, Kobarg J, Ikematsu H, Ichiyoshi Y, Casali P. Clonal analysis of a human antibody response. III. Nucleotide sequences of monoclonal IgM, IgG, and IgA to rabies virus reveal restricted V kappa gene utilization, junctional V kappa J kappa and V lambda J lambda diversity, and somatic hypermutation. J Immunol 1998, 161: 2895–905.PubMedGoogle Scholar